abstract |
The present invention is directed to neurodegenerative diseases such as Alzheimer's disease, stroke, multiple sclerosis, and head injuries, such as 5-[[3,5-bis (1,1-dimethylethyl) -4-hydroxyphenyl] methylene] -2-imide. A method of treating and preventing no-4-thiazolidinone or a pharmaceutically acceptable salt thereof. |